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THE RATIONAL THERAPY OF EAR INFECTIONS 
Yvette Attard 
Introductiun 
"The problems of deafness are deeper and more complex, if not more 
important than those of blindness. Deafness is a much worse misfortune, 
for it means the loss of the most vital stimulus - the sound of voice - that 
brings language, sets thoughts astir and keeps us in the intellectual 
company of man" (Helen Keller 1880 -1968) 
Two studies were carried out concerning ear infections at St. Luke's 
Hospital in Malta, between July and November, 1991. 
Aims 
Surveyl 
This survey dealt with ear infections in general. Its aims were to find the 
common infections, patients' age distribution, presenting signs and 
symptoms, diagnostic techniques used to identify the infections, 
pathogens and their sensitivity and resistance to antibiotics and drug 
treatment given. 
Survey 2 
This survey concerned the potentially lethal ear infection Malignant 
Otitis Externa (MOE). The aims of this survey were to find the patients' 
age distribution, common presenting signs and symptoms, diagnostic 
techniques used to identify the infection, pathogens, any correlation 
between the severity of the disease and control of diabetes mellitus, 
treatment given and its total cost. The latter includes the cost of drugs 
used to treat M.O.E., any other drugs required to treat any other 
conditions suffered by the patient, for example anti-diabetics, 
antihypertensives, any operations performed and hospital stay. 
Methodology 
Surveyl 
Analysis of patient records over 3 months was performed at the Ear, Nose 
and Throat clinic of the outpatients' department of St. Luke's Hospital 
and data collected. 
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Survey 2 
This was conducted on patients with M.O.E. who were admitted to the 
E.N.T. ward. For 5 months, patients' medical records were reviewed on 
admission and during their stay. 
A list of the Government's tender prices of the drugs used was obtained 
from the Government's Medical Stores. The daily cost of a hospital stay 
and operations' cost were obtained from the Department of Health. 
Results 
Survey 1 
Types of ear infections 
This survey was conducted on 67 patients, 38 males and 29 females. The 
age range was 4 - 77 years, the mean age being 38 years. See Table 1. 
Table 1: Types of ear infections, their percentage incidence and their most 
common presenting sign or symptom 
Ear Infection 
Chronic suppurative otitis 
media (CSOM) 
Chronic diffuse otitis externa (COE) 
Otitis media with effusion (OME) 
Acute diffuse otitis externa (AOE) 
Otomycosis 
Acute suppurative otitis media 
(ASOM) 
Furunculosis 
Adhesive otitis media 
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Incidence 
37.3 
28.3 
13.4 
11.9 
11.9 
11.9 
2.99 
2.99 
Most common 
presenting sign or 
symptom 
Perforated 
tympanic 
membrane 
Discharge 
Fluid in middle 
ear 
Otalgia 
Discharge 
Perforated 
tympanic 
membrane 
Otalgia, furuncle 
Fibrous exudate. 
hearing loss 
Diagnpsis was achieved by means of physical examination of the ear, 
tuning fork tests, pure tone audiometry, culture and sensitivity tests, 
histology, X-rays, computerised tomographic (er) scans and surgery. 
No culture and sensitivity tests were recorded for furunculosis, AOE, 
ASOM, OME and adhesive otitis media. OtomycosiS was mainly caused 
by fungi, which were not Candida albicans. The most common pathogen 
of both COE and CSOM was Pseudomonas aeruginosa. 
Among the most commonly used topical preparations were 
Dexamethasone, hydrocortisone, neomycin, sulphate and polymyxin B. 
Some of the most commonly administered systemic antibiotics were 
amoxycillin plus clavulanic acid, ampicillin and pseudoephedrine HCl. 
Survey 2 
Malignant Otitis Externa 
This survey was conducted on 9 patients, 6 males and 3 females, 90% of 
yearly cases, mean age 68.64 (age .range 52 - 92 years). All patients were 
diabetics. The oresenting signs and symptoms were recorded. 
Diagttostic techniques used to identify malignant otitis externa were the 
same as those used to diagnose other ear infections. 
The types of organisms found in the affected ear were Pseudomonas 
aeruginosa, Staphylococcus albus, Proteus, Gram-negative bacilli, 
Candida albicans and yeasts. No correlation was found between blood 
glucose-level and the severity of the disease . 
. The types of antibiotics used were the aminoglycosides, cephalosporins, 
the penicillins, erythromycin, sulphadiazine, metronidazole and 
rifampicin, giving a total of eleven combinations. Table 2 shows the 
different combfnations given to each patient and the total cost of therapy 
of each patient. 
Three different therapies-monotherapy with ceftazidime (CEFT), the 
ciprofloxacin-rifampicin (CIPR-RIF) _combination and the ceftazidime-
ciprofloxacin-rifampicin (CEFT-CIPR-RIF) combination were compared 
with the other drug combination used as treatment of M.E.O. Such 
tlllerapies were chosen since they include the newest drugs found to be 
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Table 2: The drug therapy and total cost for all the 9 patients with 
Maligp:mt OtiHs Externa 
Patient 
A' 
B 
C' 
D 
E 
F 
G 
1-1* 
Drug Combination 
Ceftazidime 
erythromycin 
gentamicin 
metronidazole 
Ceftazidime 
su Iphad iazine 
Ceftazidime 
cephalothin 
gentamicin 
metronidazole 
sulphadiazine 
Ciprofloxacin 
rifampicin 
Ceftazidime 
ciprofloxacin 
rifampicin 
Carbenicillin 
gentamicin 
metronidazole 
Amikacin 
carbenicillin 
Azlocillin 
Ceftazidime 
Amikacin 
Ampicillin / cloxacillin 
Ccftazidimc 
Gentamicin 
Metronidazole 
Ccftazidime 
Gentamicin 
Ceftazidime 
ciprofloxach, 
rifampicin 
Azlocillin 
ccftazidime 
Length of hospital stay /days 
52 
21 
72 
23 
15 
57 
97 
49 
81 
34 
72 
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'Patients A, C and 1-1 have more than one drug combination because they were admitted 
more than once to hospital. 
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Table 3 
Patient Cost of Cost of Cost of Cost of Total cost 
drugs for othcr drugs/Lm operations hospital/Lm 
treatment of stay/Lm 
malignant 
otitis extcrna 
/Lm 
A' 282.39 55.04 1.20 3120 3577.43 
423.36 27.25 1260 1710.61 
1043.17 67.11 4320 5430.28 
65.()9 7.76 1380 1452.85 
12171.17 
B 53.39 3.26 60 900 1016.65 
C' 304.75 134.66 60 3420 3919.41 
347.94 169.21 5820 6337.15 
10256.56 
D 7()9.97 31.10 2940 3681.07 
E 974.33 77.78 4860 5912.11 
F 495.77 14.83 60 2040 2610.60 
G 605.48 74.76 4320 5000.24 
H' 429.49 24.03 120 2580 3153.52 
208.45 11.97 840 1060.42 
4213.94 
230.88 13.39 60 1560 1864.27 
46726.61 
·Patic·nts A, C alid H have more than on total cost of thcrapy because thcy wcre admitted 
more than once to hospital. All prices in Maltese Lira. 
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Patient Total cost/saving Total cost/saving Total cost/saving if 
if ceft. used/LM if cipr. rif. ceft. ci pr. rif. 
combination combination used/LM 
used/LM 
A 73:2:7.78 4792.95 5983.75 6186.98 12171.86 -1.13* 
B 1852.42 308.32 1506.09 1556.93 1016.65 / 
C 3748.54 6508.51 3044.64 7217.41 6187.06 4069.99 
0 1813.98 762,94 1465.53 1110.64 3012.18 -431.58* 
E 1815.85 4095.55 1467.18 4444.22 3015.33 3229.15 
F 1862.22 747.65 1515.12 1094.75 3052.27 -1102.40* 
G 1835.18 308.32 1484.28 1556.93 5018.98 / 
H 3728.50 G> 1525.88 2221.28 3033.84 6111.42 -863.16* 
I 1864.27 / 1516.94 347.33 3055.74 -1191.47* 
25898.74 19050.12 21017.37 25731.47 42641.49 3709.40 
*The minus sign indicates that losses would have been involved if one of the three 
particular regimens were used in that case. 
Table 4: Total cost of treatment and saving of all the 9 patients with 
malignant otitis externa if the three particular regimens were 
used 
effective.in the treatment of the infection. Table 4 shows the total cost 
of treatment and total savings for all the 9 patients, for each individual 
when treated with the three particular regimens. 
Thus the'total savings that would have been involved are: 
1) Ceftazidime only: Lm19,050: 12, i.e. 40.8% of the actual total cost 
of treatment of all the 9 patients (Lm46,726.61) 
2) Ciprofloxacin and rifampicin: Lm25,731.47, i.e. 55.1%. 
3) Ceftazidime, ciprofloxacin and rifampicin: Lm3,709.40, i.e. 7.94% 
Alternatively, the savings associal",d with each patient would have 
been 4.5% if ceftazidime was used, 6.1 % if ciprofloxacin and rifampicin 
was used and 0.9% if ceftazidime-ciprofloxacin-rifampicin combination 
was used. 
Discussion and Conclusions 
Survey 1: Cases registered shoVvC:u that ear infections can occur in all age 
groups without preference. The mo~t common infections were found to be 
CSOM and COE. Had diffuse otitis externa not been divided into acute 
and chronic stages, the percentage incidence of this infection would be 
grater than that of CSOM. 
Some presenting signs and symptoms can be simila.r for the different ear 
infections. However, other signs and symptoms are specific to a 
particular infection. Thus diagnostic. techniques are very important for 
thorough examination of the ear, identification of the signs and 
symptoms and hence the particular infection and correct treatment. 
rhe most common pathogen of both· COE and CSOM was Pseudomonas 
a{!ruginosa. This was also reported in a previous study (Yagi, 1990). 
Various drugs 'were used in the treatment of ear infections. The 
antibiotics were prescribed topically, namely in the form of ear drops and 
creams, the former being much more common, and systemically, namely 
periorally, intramuscularly and intravenously, periorally being the most 
common. Topical steroids were also prescribed in combination with 
topical antibiotics. In fact, the most common topical preparations used 
wre hydrocortisone, neomycin sulphate, polymyxin B sulphate plus 
to;naftate drops and dexamethasone, framycetin sulphate and 
432 
gramicidin drops. The most common systemic antibiotics were 
amoxycillin plus clavulanic acid, ampicillin and erythromycin. 
Survey 2: Malignant otitis externa, also termed necrotising otitis externa, 
is.both an important and interesting clinical entity. It is a potentially 
lethal disease affecting patients who are usually elderly and diabetic in 
whom. Pseudomonas .aeruginosa causes an osteomyelitis of the skull base, 
using the external ear as a port of entry (Sade et aI, 1989). In fact all 
patients in the study were elderly diabetics and the most common 
pathogen was Ps. aeruginosa. The microangiopathy of diabetes, 
specifically microangiopathy of the skin of the external auditory 
meatus, results in local tissu~ perfusion and creates an environment well 
suited for invasion by Ps. aeruginosa (Doroghazi et al., 1981). 
Blood glucose level was not found to be an indication of the severity of 
the· disease. This was also reported in a previous study (Doroghazi et 
al" 1981). 
Prompt diagnosis and correct treatment are very important -to avoid 
extension of the inflammation and neurological complications. Thus 
diagnostic techniques are essential for correct diagnosis. 
Various combinations of antibiotics haye been used in Malta throughout 
the years, in accordance with the current therapy used in other countries 
for the disease in question. 
In the present study, it was found that monotherapy with ceftazidime, 
the ciprofloxacin-rifampicin. combination and the ceftazidime-
ciprofloxacin-rifampicin .combination ate all cost-effective because the 
total cost of therapy is cheaper than that of the other therapies and the 
drugs are safer than the others. The most cost-effective therapy was 
found to be the ciprofloxacin-rifampicin combination, ciprofloxacin being 
given SOO-7SOmg and rifampicit;\- 600mg, both twice daily and periorally. 
Using the ciprofloxac\n-rifampicin combination, the disease can be 
trated without the patient being admitted to hospital or at least for a 
short period of time for observation. The results given previously are 
theoretical and could be subject to some change. 
Malignant otitis externa seems to be more common in Malta than in other 
countries. This is probably due to the fact that diabetes has a relativley 
high incidence in Malta (9.8%) compared to other countries (5.2%) 
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(Papoz, 1990) and that Malta has a hot and humid climate, both faCtors 
being prognostic for M.O.E. 
The pharmacist has a role in the treatment of ear infections both in the 
community and at hospital. He/she can give advice on the proper use of 
ear drops (e.g. 2 or 3 drops should be placed in the affected ear with the 
head tilted on the other side and kept thus for five minutes to ensure 
adequate contact of the active ingredients with the infected areas) as 
this is mandatory for effective treatment of the infection.. At hospital, 
the pharmacist can ensure that the patients are compliant, that is, they 
are taking the prescribed drugs appropriately. He/she can also monitor 
the drug blood levels of patients to whom ototoxic and/or nephrotoxic 
drugs such as the aminoglycosides are administered. Thus the 
pharmacist can be an important member of the health care team for the 
treatment of patients suffering from ear infections. 
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